Indian drug in 4 years

Indian pharma majors may manage to market their first indigenous “blockbuster drugs” or new chemical entities (NCEs) in the next four years.

NCE is nothing but the global industry terminology for new drug. Till now Indian Pharma companies are manufacturing off-patent medicine. They are waiting for many drugs to go off-patent so that they can sell those drugs. If they are successful in developing new molecule they will have a great market and have right to sell them all over the world if they get them patented.

The major pharma companies have reached to the top position because of their NCE medicine. The Lipitor from Pfizer do a business of $12 billion per year. This is the highest selling drug of the world in terms of revenue. For the development of new molecule the Indian companies are collaborating with foreign companies. This is a good strategy as it will help them to develop the product at a lesser time. Again it will help them to trial the medicine across various region of the world.

Ranbxy is developing the medicine for malaria where as Dr. Reddy is developing medicine for Diabetes. All the medicines being developed are in their second phase. It will take 4 to 6 years to launch these medicines. Once these medicines are launched it will bring healthy revenue for the company as well as the economy. This will make the Indian pharma company strong as till now they have not developed any new medicine of their own. Our R&D industry is already booming. This will increase the pace of this sector.